Fierce Healthcare April 3, 2024
Dave Muoio

To address the nation’s drug shortages, the Department of Health and Human Services (HHS) is floating a plan that would attach new Medicare payments and penalties to hospitals’ supply chain practices.

This program, which was described in a white paper released yesterday alongside another focused on drug manufacturers, would require new authorities from Congress and would be phased in over the course of several years.

The so-called Hospital Resilient Supply Program (HRSP) would see hospitals graded on a “scorecard that would be a combination of attestations and ratings reflecting the hospitals’ achievement and progress in adopting practices that promote supply chain resilience or prevent shortages,” HHS wrote in the white paper.

Hospitals, HHS wrote, could potentially be rewarded for managing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, HHS, Insurance, Medicare, Pharma, Pharma / Biotech, Provider, Supply Chain, Technology
Not 1, Not 2, but 6 Settlements
How Does the Department of Health and Human Services (HHS) Impact Health and Health Care?
How Healthcare Leaders Reacted to the 15 Additional Drugs Selected for Medicare Negotiation Program
STAT+: Trump finally finds a populist health care message in Kennedy’s MAHA
Lawmakers, experts weigh in on Medicare Drug Price Negotiation Program

Share This Article